Furthermore, we will also aim to investigate whether some of these differentially secreted proteins may constitute a secreted signature detectable in PDAC patients’ sera that can be easily predictive for GOF TP53 gene mutations in cancer patients. This evidence concerns the gene TP53 and cancer.